EffRx Pharmaceuticals signs exclusive license agreement with Diurnal for registration and commercialisation of Alkindi

EffRx Pharmaceuticals has signed exclusive license agreement with Diurnal for registration and commercialisation of Alkindi. (Credit: Frauke Feind from Pixabay)